Alan Karthikesalingam
Alan is a Principal Scientist and Director at Google DeepMind working on biomedical AI. He cofounded and leads AI co-clinician and AI co-scientist; and previously founded and led precursors in AMIE, Med-PaLM, Med-PaLM-2 and Med-PaLM-Multimodal. His research in over 10 full Nature/Nature-Medicine publication spans breakthroughs for conversational and diagnostic AI systems in multiple domains. These include the first example of an AI system passing medical license-style examinations, competently undertaking medical consultations, and solving multimodal diagnostic challenges spanning cardiology, radiology, oncology, ophthalmology, dermatology and electronic health records.
He is an honorary Lecturer in Vascular Surgery at Imperial College in London. He completed his MA in Neuroscience and Medical Degree (MBBChir) at the University of Cambridge before specialist training in surgery in the London Deanery, where he completed his Membership of the Royal College of Surgeons (MRCS), PhD in Vascular Surgery and appointment as NIHR Clinical Lecturer. Prior to joining Google DeepMind Alan had published over 150 peer-reviewed articles including first-author studies in the New England Journal of Medicine and The Lancet.
Research Areas
Authored Publications
Sort By
Towards Conversational AI for Disease Management
Khaled Saab
David Stutz
Yong Cheng
Kavita Kulkarni
Sara Mahdavi
Joelle Barral
James Manyika
Ryutaro Tanno
Adam Rodman
Nature (2026)
Preview abstract
While large language models (LLMs) have shown promise in diagnostic dialogue, their capabilities for effective management reasoning - including disease progression, therapeutic response, and safe medication prescription - remain under-explored. We advance the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE) through a new LLM-based agentic system optimised for clinical management and dialogue, incorporating reasoning over the evolution of disease and multiple patient visit encounters, response to therapy, and professional competence in medication prescription. To ground its reasoning in authoritative clinical knowledge, AMIE leverages Gemini's long-context capabilities, combining in-context retrieval with structured reasoning to align its output with relevant and up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination (OSCE) study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multi-visit case scenarios designed to reflect UK NICE Guidance and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning as assessed by specialist physicians and scored better in both preciseness of treatments and investigations, and in its alignment with and grounding of management plans in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark derived from two national drug formularies (US, UK) and validated by board-certified pharmacists. While AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher difficulty questions. While further research would be needed before real-world translation, AMIE's strong performance across evaluations marks a significant step towards conversational AI as a tool in disease management.
View details
CoDaS: AI Co-Data-Scientist for Biomarker Discovery via Wearable Sensors
Juro Gottweis
CJ Park
Salman Rahman
Ahmed Metwally
Hong Yu
Ivor Rendulic
Yuzhe Yang
Petar Sirkovic
Daniel McDuff
Shwetak Patel
Nicolas Stroppa
Yubin Kim
Mark Malhotra
Orson Xu
Sam Schmidgall
Tim Althoff
Elahe Vedadi
Cynthia Breazeal
Hae Won Park
(2026)
Towards Physician-Level Medical Question Answering with Large Language Models
Karan Singhal
Juro Gottweis
Le Hou
Kevin Clark
Heather Cole-Lewis
Amy Wang
Sami Lachgar
Philip Mansfield
Sushant Prakash
Bradley Green
Ewa Dominowska
Nenad Tomašev
Renee Wong
Sara Mahdavi
Joelle Barral
Nature Medicine (2025) (to appear)
Preview abstract
Recent artificial intelligence (AI) systems have reached milestones in "grand challenges" ranging from Go to protein-folding. The capability to retrieve medical knowledge, reason over it, and answer medical questions comparably to physicians has long been viewed as one such grand challenge.
Large language models (LLMs) have catalyzed significant progress in medical question answering; Med-PaLM was the first model to exceed a "passing" score in US Medical Licensing Examination (USMLE) style questions with a score of 67.2% on the MedQA dataset. However, this and other prior work suggested significant room for improvement, especially when models' answers were compared to clinicians' answers. Here we present Med-PaLM 2, which bridges these gaps by leveraging a combination of base LLM improvements (PaLM 2), medical domain finetuning, and prompting strategies including a novel ensemble refinement approach.
Med-PaLM 2 scored up to 86.5% on the MedQA dataset, improving upon Med-PaLM by over 19% and setting a new state-of-the-art. We also observed performance approaching or exceeding state-of-the-art across MedMCQA, PubMedQA, and MMLU clinical topics datasets.
We performed detailed human evaluations on long-form questions along multiple axes relevant to clinical applications. In pairwise comparative ranking of 1066 consumer medical questions, physicians preferred Med-PaLM 2 answers to those produced by physicians on eight of nine axes pertaining to clinical utility (p < 0.001). We also observed significant improvements compared to Med-PaLM on every evaluation axis (p < 0.001) on newly introduced datasets of 240 long-form "adversarial" questions to probe LLM limitations.
While further studies are necessary to validate the efficacy of these models in real-world settings, these results highlight rapid progress towards physician-level performance in medical question answering.
View details
Generative AI for medical education: Insights from a case study with medical students and an AI tutor for clinical reasoning
Amy Wang
Roma Ruparel
Paul Jhun
Julie Anne Seguin
Patricia Strachan
Renee Wong
CHI (2025) (to appear)
Preview abstract
Generative Artificial Intelligence (AI), particularly Large Language Models (LLMs), have demonstrated significant potential in clinical reasoning skills such as history-taking and differential diagnosis generation—critical aspects of medical education. This work explores how LLMs can augment medical curricula through interactive learning. We conducted a participatory design process with medical students, residents and medical education experts to co-create an AI-powered tutor prototype for clinical reasoning. As part of the co-design process, we conducted a qualitative user study, investigating learning needs and practices via interviews, and conducting concept evaluations through interactions with the prototype. Findings highlight the challenges learners face in transitioning from theoretical knowledge to practical application, and how an AI tutor can provide personalized practice and feedback. We conclude with design considerations, emphasizing the importance of context-specific knowledge and emulating positive preceptor traits, to guide the development of AI tools for medical education.
View details
Towards Conversational Diagnostic AI
Khaled Saab
Jan Freyberg
Ryutaro Tanno
Amy Wang
Brenna Li
Nenad Tomašev
Karan Singhal
Yong Cheng
Le Hou
Albert Webson
Kavita Kulkarni
Sara Mahdavi
Juro Gottweis
Joelle Barral
Kat Chou
Nature (2025) (to appear)
Preview abstract
At the heart of medicine lies the physician-patient dialogue, where skillful history-taking paves the way for accurate diagnosis, effective management, and enduring trust. Artificial Intelligence (AI) systems capable of diagnostic dialogue could increase accessibility, consistency, and quality of care. However, approximating clinicians' expertise is an outstanding grand challenge. Here, we introduce AMIE (Articulate Medical Intelligence Explorer), a Large Language Model (LLM) based AI system optimized for diagnostic dialogue.
AMIE uses a novel self-play based simulated environment with automated feedback mechanisms for scaling learning across diverse disease conditions, specialties, and contexts. We designed a framework for evaluating clinically-meaningful axes of performance including history-taking, diagnostic accuracy, management reasoning, communication skills, and empathy. We compared AMIE's performance to that of primary care physicians (PCPs) in a randomized, double-blind crossover study of text-based consultations with validated patient actors in the style of an Objective Structured Clinical Examination (OSCE). The study included 149 case scenarios from clinical providers in Canada, the UK, and India, 20 PCPs for comparison with AMIE, and evaluations by specialist physicians and patient actors. AMIE demonstrated greater diagnostic accuracy and superior performance on 28 of 32 axes according to specialist physicians and 24 of 26 axes according to patient actors. Our research has several limitations and should be interpreted with appropriate caution. Clinicians were limited to unfamiliar synchronous text-chat which permits large-scale LLM-patient interactions but is not representative of usual clinical practice. While further research is required before AMIE could be translated to real-world settings, the results represent a milestone towards conversational diagnostic AI.
View details
AI mirrors experimental science to uncover a novel mechanism of gene transfer crucial to bacterial evolution
Juro Gottweis
Jose R Penades
Alexander Daryin
Artiom Myaskovsky
Tiago R D Costa
Cell (2025)
Preview abstract
Note this is a re-submission of a previously approved ITP. The previous approval was conditional for a journal pre-sub enquiry only and we are submitting a new ITP for the preprint of the paper.
AI models have been proposed for hypothesis generation, but testing their ability to drive
high-impact research is challenging, since an AI-generated hypothesis can take decades to
validate. Here, we challenge the ability of a recently developed LLM-based platform to
generate high-level hypotheses by posing a question that took years to resolve
experimentally but remained unpublished: How could capsid-forming phage-inducible
chromosomal islands (cf-PICIs) spread across bacterial species? Remarkably, the AI’s top-
ranked hypothesis matched our experimentally confirmed mechanism: cf-PICIs hijack
diverse phage tails to expand their host range. We critically assess the AI’s five highest-
ranked hypotheses, showing that some opened new research avenues in our laboratories.
We benchmark its performance against other LLMs and outline best practices for integrating
AI into scientific discovery. Our findings suggest that AI can act not just as a computational
tool, but as a creative engine, accelerating discovery and reshaping how we generate and
test scientific hypotheses.
View details
Creating an Empirical Dermatology Dataset Through Crowdsourcing With Web Search Advertisements
Abbi Ward
Jimmy Li
Julie Wang
Sriram Lakshminarasimhan
Ashley Carrick
Jay Hartford
Pradeep Kumar S
Sunny Virmani
Renee Wong
Margaret Ann Smith
Dawn Siegel
Steven Lin
Justin Ko
JAMA Network Open (2024)
Preview abstract
Importance: Health datasets from clinical sources do not reflect the breadth and diversity of disease, impacting research, medical education, and artificial intelligence tool development. Assessments of novel crowdsourcing methods to create health datasets are needed.
Objective: To evaluate if web search advertisements (ads) are effective at creating a diverse and representative dermatology image dataset.
Design, Setting, and Participants: This prospective observational survey study, conducted from March to November 2023, used Google Search ads to invite internet users in the US to contribute images of dermatology conditions with demographic and symptom information to the Skin Condition Image Network (SCIN) open access dataset. Ads were displayed against dermatology-related search queries on mobile devices, inviting contributions from adults after a digital informed consent process. Contributions were filtered for image safety and measures were taken to protect privacy. Data analysis occurred January to February 2024.
Exposure: Dermatologist condition labels as well as estimated Fitzpatrick Skin Type (eFST) and estimated Monk Skin Tone (eMST) labels.
Main Outcomes and Measures: The primary metrics of interest were the number, quality, demographic diversity, and distribution of clinical conditions in the crowdsourced contributions. Spearman rank order correlation was used for all correlation analyses, and the χ2 test was used to analyze differences between SCIN contributor demographics and the US census.
Results: In total, 5749 submissions were received, with a median of 22 (14-30) per day. Of these, 5631 (97.9%) were genuine images of dermatological conditions. Among contributors with self-reported demographic information, female contributors (1732 of 2596 contributors [66.7%]) and younger contributors (1329 of 2556 contributors [52.0%] aged <40 years) had a higher representation in the dataset compared with the US population. Of 2614 contributors who reported race and ethnicity, 852 (32.6%) reported a racial or ethnic identity other than White. Dermatologist confidence in assigning a differential diagnosis increased with the number of self-reported demographic and skin-condition–related variables (Spearman R = 0.1537; P < .001). Of 4019 contributions reporting duration since onset, 2170 (54.0%) reported onset within less than 7 days of submission. Of the 2835 contributions that could be assigned a dermatological differential diagnosis, 2523 (89.0%) were allergic, infectious, or inflammatory conditions. eFST and eMST distributions reflected the geographical origin of the dataset.
Conclusions and Relevance: The findings of this survey study suggest that search ads are effective at crowdsourcing dermatology images and could therefore be a useful method to create health datasets. The SCIN dataset bridges important gaps in the availability of images of common, short-duration skin conditions.
View details
Safety principles for medical summarization using generative AI
Dillon Obika
Christopher Kelly
Nicola Ding
Chris Farrance
Praney Mittal
Donny Cheung
Heather Cole-Lewis
Madeleine Elish
Nature Medicine (2024)
Preview abstract
The introduction of Generative AI, particularly large language models presents exciting opportunities for healthcare. However their novel capabilities also have the potential to introduce novel risks and hazards. This paper explores the unique safety challenges associated with LLMs in healthcare, using medical text summarization as a motivating example. Using MedLM as a case example, we propose leveraging existing standards and guidance while developing novel approaches tailored to the specific characteristics of LLMs.
View details
Quantifying urban park use in the USA at scale: empirical estimates of realised park usage using smartphone location data
Michael T Young
Swapnil Vispute
Stylianos Serghiou
Akim Kumok
Yash Shah
Kevin J. Lane
Flannery Black-Ingersoll
Paige Brochu
Monica Bharel
Sarah Skenazy
Shailesh Bavadekar
Mansi Kansal
Evgeniy Gabrilovich
Gregory A. Wellenius
Lancet Planetary Health (2024)
Preview abstract
Summary
Background A large body of evidence connects access to greenspace with substantial benefits to physical and mental
health. In urban settings where access to greenspace can be limited, park access and use have been associated with
higher levels of physical activity, improved physical health, and lower levels of markers of mental distress. Despite the
potential health benefits of urban parks, little is known about how park usage varies across locations (between or
within cities) or over time.
Methods We estimated park usage among urban residents (identified as residents of urban census tracts) in
498 US cities from 2019 to 2021 from aggregated and anonymised opted-in smartphone location history data. We
used descriptive statistics to quantify differences in park usage over time, between cities, and across census tracts
within cities, and used generalised linear models to estimate the associations between park usage and census tract
level descriptors.
Findings In spring (March 1 to May 31) 2019, 18·9% of urban residents visited a park at least once per week, with
average use higher in northwest and southwest USA, and lowest in the southeast. Park usage varied substantially
both within and between cities; was unequally distributed across census tract-level markers of race, ethnicity, income,
and social vulnerability; and was only moderately correlated with established markers of census tract greenspace. In
spring 2019, a doubling of walking time to parks was associated with a 10·1% (95% CI 5·6–14·3) lower average
weekly park usage, adjusting for city and social vulnerability index. The median decline in park usage from spring
2019 to spring 2020 was 38·0% (IQR 28·4–46·5), coincident with the onset of physical distancing policies across
much of the country. We estimated that the COVID-19-related decline in park usage was more pronounced for those
living further from a park and those living in areas of higher social vulnerability.
Interpretation These estimates provide novel insights into the patterns and correlates of park use and could enable
new studies of the health benefits of urban greenspace. In addition, the availability of an empirical park usage metric
that varies over time could be a useful tool for assessing the effectiveness of policies intended to increase such
activities.
View details
Towards Generalist Biomedical AI
Danny Driess
Andrew Carroll
Chuck Lau
Ryutaro Tanno
Ira Ktena
Basil Mustafa
Aakanksha Chowdhery
Simon Kornblith
Philip Mansfield
Sushant Prakash
Renee Wong
Sunny Virmani
Sara Mahdavi
Bradley Green
Ewa Dominowska
Joelle Barral
Karan Singhal
Pete Florence
NEJM AI (2024)
Preview abstract
BACKGROUND: Medicine is inherently multimodal, requiring the simultaneous interpretation and integration of insights between many data modalities spanning text, imaging, genomics, and more. Generalist biomedical artificial intelligence systems that flexibly encode, integrate, and interpret these data might better enable impactful applications ranging from scientific discovery to care delivery.
METHODS: To catalyze development of these models, we curated MultiMedBench, a new multimodal biomedical benchmark. MultiMedBench encompasses 14 diverse tasks, such as medical question answering, mammography and dermatology image interpretation, radiology report generation and summarization, and genomic variant calling. We then introduced Med-PaLM Multimodal (Med-PaLM M), our proof of concept for a generalist biomedical AI system that flexibly encodes and interprets biomedical data including clinical language, imaging, and genomics with the same set of model weights. To further probe the capabilities and limitations of Med-PaLM M, we conducted a radiologist evaluation of model-generated (and human) chest x-ray reports.
RESULTS: We observed encouraging performance across model scales. Med-PaLM M reached performance competitive with or exceeding the state of the art on all MultiMedBench tasks, often surpassing specialist models by a wide margin. In a side-by-side ranking on 246 retrospective chest x-rays, clinicians expressed a pairwise preference for Med-PaLM Multimodal reports over those produced by radiologists in up to 40.50% of cases, suggesting potential clinical utility.
CONCLUSIONS: Although considerable work is needed to validate these models in real-world cases and understand if cross-modality generalization is possible, our results represent a milestone toward the development of generalist biomedical artificial intelligence systems.
View details
